Literature DB >> 17277717

Recent advances in the treatment and management of excessive daytime sleepiness.

Jed Black1, Stephen P Duntley, Richard K Bogan, Mary B O'Malley.   

Abstract

Excessive daytime sleepiness (EDS) is a prevalent complaint among patients in psychiatric care. Patients with conditions of EDS have often been misdiagnosed with depression due to their complaints of lack of energy, poor concentration, memory disturbance, and a reduced interest in life. Impaired alertness associated with EDS can be detrimental to a person's quality of life by causing decreased work performance, self-consciousness, low self esteem, and social isolation. Excessive sleepiness is also associated with various health problems, comorbid medical and psychiatric conditions, and fatal accidents occurring after the driver has fallen asleep at the wheel. Contributing factors leading to EDS range from insufficient sleep hours to central nervous system-mediated debilitating hypersomnolence. Circadian rhythm disorders, sleep disorders such as obstructive sleep apnea and narcolepsy, and medications that cause sleepiness may also contribute to symptoms of EDS. Recognition of the symptoms of sleep deprivation is essential, as many such patients do not have a clear awareness of their own sleepiness. Treatment options, depending upon the condition, include light therapy or appropriate airway management techniques such as nasal continuous positive airway pressure (CPAP). Occasionally, wakefulness-promoting medications are necessary, particularly in patients with narcolepsy. In this expert roundtable supplement, Stephen P. Duntley, MD, reviews the definition and prevalence of EDS and discusses the contributing factors and consequences of daytime sleepiness. Next, Richard K. Bogan, MD, FCCP, gives an overview of the differential diagnosis of EDS and the assessment tools available for identifying sleepiness in symptomatic patients. Finally, Mary B. O'Malley, MD, PhD, reviews treatment of EDS, including counseling on sleep hygiene and duration of sleep, mechanical treatments, bright-light therapy, and wake-promoting medications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277717     DOI: 10.1017/s1092852900028376

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  6 in total

1.  Antipsychotic-induced somnolence in mothers with schizophrenia.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2012-03

2.  The Brazilian-Portuguese version of the Sleep Hygiene Index (SHI): validity, reliability and association with depressive symptoms and sleep-related outcomes.

Authors:  André Comiran Tonon; Guilherme Rodriguez Amando; Alicia Carissimi; Juliana Jury Freitas; Nicóli Bertuol Xavier; Guilherme Hidalgo Caumo; Luka Gawlinski Silva; Diogo Onofre Gomes de Souza; Maria Paz Hidalgo
Journal:  Sleep Sci       Date:  2020 Jan-Mar

3.  Daytime sleepiness in elderly Parkinson's disease patients and treatment with the psychostimulant modafinil: A preliminary study.

Authors:  Johan Lökk
Journal:  Neuropsychiatr Dis Treat       Date:  2010-04-07       Impact factor: 2.570

Review 4.  Clinical diagnosis and misdiagnosis of sleep disorders.

Authors:  G Stores
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12       Impact factor: 10.154

5.  Improvement in Fatigue, Sleepiness, and Health-Related Quality of Life with Bright Light Treatment in Persons with Seasonal Affective Disorder and Subsyndromal SAD.

Authors:  Cecilia Rastad; Jan Ulfberg; Per Lindberg
Journal:  Depress Res Treat       Date:  2011-06-13

6.  Toward a classification of medications for sleep and circadian rhythm disorders.

Authors:  Michael J Thorpy; Thomas Roth
Journal:  Nat Sci Sleep       Date:  2013-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.